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Abstract
Studies indicate that diet and vascular calcification may be related to the occurrence of brain lesions,
although the importance of dietary calcium and vitamin D has not been investigated. The objective
of this study was to test the hypothesis that calcium and vitamin D intakes would be positively
associated with brain lesion volumes in elderly individuals with and without late-life depression. A
cross sectional study was performed as part of a longitudinal clinical study of late-life depression.
Calcium and vitamin D intakes were assessed in 232 elderly subjects (95 with current or prior
depression, 137 without depression) using a Block 1998 food frequency questionnaire. Calcium,
vitamin D, and kilocalorie intake were determined. Brain lesion volumes were calculated from
magnetic resonance imaging scan. Subjects were age 60 years or over. Calcium and vitamin D intakes
were significantly and positively correlated with brain lesion volume (p < 0.05 and p < 0.001,
respectively). In two separate multivariable models, controlling for age, hypertension, diabetes, heart
disease, group (depression/comparison), lesion load (high/low), and total kilocalories, these positive
associations remained significant (p<0.05 for calcium; p < 0.001 for vitamin D). In conclusion,
calcium and vitamin D consumption were associated with brain lesions in elderly subjects, even after
controlling for potentially explanatory variables. These associations may be due to vascular
calcification or other mechanism. The possibility of adverse effects of high intakes of calcium and
vitamin D needs to be further explored in longitudinal studies of elderly subjects.
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Brain lesions seen on magnetic resonance imaging (MRI) (Fig. 1) are indicative of damage to
gray and white matter [1] and are associated both cross-sectionally and longitudinally with
cognitive dysfunction [2,3], dementia [4], stroke [5], late-life depression [6], and functional
impairment [7]. Lesions are known to be associated with both the persistence and worsening
of depressive symptoms [6,8]. Research into the causes of brain lesions is critical to
understanding the occurrence and progression of numerous afflictions of late-life.
Calcium dysregulation is important in chronic diseases such as osteoporosis and
atherosclerosis, as well as in nervous system disorders such as dementia and depression [9–
12]. Calcification of vascular smooth muscle occurs with aging, renal disease, and
atherosclerosis, and has been associated with brain lesions and cognitive impairment [13,14].
The importance of diet to brain lesions remains uncertain. In small studies high doses of calcium
and vitamin D have been associated with vascular calcification [15,16]. High intakes of calcium
were found to be associated with coronary artery calcification in a small sample (n=39) of
young adults with end-stage renal disease [15]. Administration to rats (n=47) of calcitriol, the
hormonal form of vitamin D, was found to cause vascular calcification [16].
Depressed individuals may be especially susceptible to the effects of calcium dysregulation;
reports confirm a higher prevalence of calcification [17] and disturbances of calcium
metabolism in depressed patients [9,18]. In addition, dietary calcium itself has been found to
promote learned helplessness, an animal model of depression, in rats [19]. One study of elderly
subjects found carotid atherosclerosis to be related to brain lesions only in those with depression
[20]. Our group previously found that high-fat dairy consumption was positively associated
with brain lesion volumes in depressed elders [21]. However, since high-fat dairy was
correlated with overall dairy consumption, we speculated that other dairy nutrients, particularly
those related to calcium metabolism, might be responsible for the dairy-lesion association.
Examination of a possible relationship between dietary calcium and vitamin D, and brain
lesions is critical for a number of reasons. The aging of the population will likely increase the
prevalence of brain lesions and their sequelae, including cognitive impairment and depression.
Late-life depression, considered to be related to obesity [22] and the metabolic syndrome
[23,24], may also increase secondary to rising obesity rates [25]. These population changes
come at a time when calcium and vitamin D supplementation is being encouraged in an effort
to prevent osteoporosis and other diseases of late-life [26,27]. In addition, vitamin D intake
recommendations are being revised upwards [28]. The impact of these dietary changes on brain
health and psychological well-being needs to be examined.
The present study was conducted in a group of geriatric individuals with and without
depression. The goal was to determine whether calcium and vitamin D intakes were associated
with brain lesion volume. The hypothesis was that reported intakes of both calcium and vitamin
D would be positively correlated with brain lesion volume. In addition, we hypothesized that
depression might accentuate this association because of differences in calcium metabolism and
vascular calcification among depressives [17,18].
2. Methods and materials
2.1. Design
This cross-sectional project occurred within a larger longitudinal clinical study of depression
in older adults (Longitudinal Study of Depression in Later Life and the Conte Center for the
Neuroscience of Depression). Subjects have been followed for this project for up to 14 years;
the nutrition assessment was paired with the closest available MRI and clinical assessment
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data. The rationale for this project was to determine if an association exists between dietary
calcium and vitamin D, and brain lesion volumes in depressed and non-depressed elders.
2.2. Sample
This sample included patients of the Duke University Psychiatric Service with a primary
diagnosis of major depression at study baseline and comparison subjects recruited from the
Aging Center Subject Registry at Duke University [29]. Enrollment was restricted to those 60
years or older, and those who could speak and write English.
Exclusion criteria included a concurrent diagnosis of a major psychiatric or neurological
illness, significant cognitive impairment (as indicated by a Mini-Mental State Examination
score of less than 24 out of 30) [30], and metal in body (contraindicated for MRI). In addition,
subjects with severe depression symptomatology were excluded because of concerns about
subject burden. This criterion did not require a specific depression rating cut-off but was instead
determined by the treating psychiatrist on a case-by-case basis.
Comparison subjects were required to have a non-focal neurological examination, self-report
of no neurological or depressive illness, and no evidence of a depression diagnosis based on
the Diagnostic Interview Schedule portion of the Duke Depression Evaluation Schedule [31].
After complete description of the study to the subjects, written informed consent was obtained.
This research protocol has been reviewed and approved by the Duke University Medical Center
Institutional Review Board.
2.3. Treatment
Depression subjects received individualized treatment from a psychiatrist [29]. Most received
antidepressant medications which include selective serotonin reuptake inhibitors. Some
subjects received electroconvulsive treatment or psychotherapy. Depression subjects were seen
quarterly by their study psychiatrist, or more often if clinically indicated. Comparison subjects
received no psychiatric treatment or medical intervention but they did come to clinic yearly
for research assessments.
2.4. Measures
Assessments included psychiatric [29], medical [31], nutrition [32], and imaging [33]
measures. At baseline and yearly thereafter a trained interviewer administered the Duke
Depression Evaluation Schedule (DDES) [34] in-person to each subject. The DDES, a
composite diagnostic interview instrument, included sections of the NIMH (National Institute
of Mental Health) Diagnostic Interview Schedule which assesses depression, and was enriched
with items on physical health [31]. Clinical assessments, including the Montgomery-Asberg
Depression Rating (MADRS), were performed at study baseline and quarterly thereafter [35].
Nutrition assessments were administered annually [32]. Brain MRI was performed every two
years, starting at study baseline [33].
2.4.1. Nutrition protocol—The nutrition subproject has been described previously [32].
The 1998 Block Food Frequency Questionnaire (FFQ) was used for nutrition assessment. This
tool is an updated version of the FFQ developed by Gladys Block at the National Cancer
Institute. The Block FFQ was designed to estimate the components of a person’s total dietary
intake over the preceding year [36]. Returned questionnaires were checked for completeness
and rejected if more than 15 food items were skipped. Intake estimates included total
kilocalories, calcium from foods, vitamin D from foods, calcium from dietary supplements,
and vitamin D from dietary supplements. Food sources of calcium include dairy products (milk,
cheese, yogurt, and ice cream), beans, fortified orange juice, almonds, and some green
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vegetables [37]. Vitamin D food sources include fortified milk, eggs, fish, fortified orange
juice, fortified cereals, and mushrooms [37].
2.4.2. Magnetic resonance imaging (MRI)—Subjects were imaged with a 1.5 Tesla
whole-body MRI system (Signa, GE Medical Systems, Milwaukee, WI) under an IRB-
approved protocol. The pulse sequence parameters have been described previously [33]. The
MR images were processed for lesion volumes by blinded analysts (blinded to all identifying
information, including depression diagnosis and dietary intake) in the Neuropsychiatric
Imaging Research Laboratory (NIRL). In addition, the scans were qualitatively assessed for
the presence of lesions by a neuroradiologist.
2.4.2.1. Lesion assessment (qualitative): Both T1- and T2-weighted pulse sequences were
visually examined for incidental findings and lesion ratings. Lesion ratings performed for this
study have been described previously [33]. Ratings included the following Coffey scale items:
Deep white matter hyperintensity (lesion-intense regions within the white matter tracts of
cerebrum): 0 - absent; 1 - punctate foci; 2 - beginning confluence of foci; 3 - large confluent
areas
Subcortical gray matter hyperintensity (lesion-intense regions within the basal ganglia and
other subcortical gray matter structures): 0 - absent; 1 - punctate; 2 -multi-punctate; 3 – diffuse
Subjects who received a rating of 2 or higher on either subcortical gray or deep white
hyperintensities were categorized as having high lesion load; otherwise, they were categorized
as having low lesion load. This criterion has been used previously for distinguishing vascular
(high lesion load) depression from non-vascular depression [38]. Lesion load for this study
was assessed from the earliest available MRI.
2.4.2.2. Quantitative brain assessments (including lesion volumes): A dual-echo fast spin-
echo axial acquisition was used for volumetric measurement of brain structures, including gray
and white matter lesions. NIRL image processing procedures have been described previously
[33]. The method is a supervised, semi-automated method that uses the multiple MR contrasts
available to identify different tissue classifications through a ‘seeding’ process wherein a
trained analyst manually selects pixels in each tissue type that are to be identified (such as gray
matter, white matter, cerebrospinal fluid, lesions, background). Gray and white matter lesion
areas were selected based upon a set of rules that allow trained analysts to reliably select lesion
regions. Periventricular lesions were defined as regions that were contiguous with lateral
ventricle and did not extend into the white matter tracts. These lesions were classified as white
matter lesions. Deep white matter lesions were located in the white matter tracts and may or
may not have adjoined periventricular lesions. Subcortical gray matter lesions were defined as
lesions within the basal ganglia or thalamus. Total lesion volumes were comprised of both gray
matter lesions and white matter lesions, although white matter lesions predominated.
2.5. Analyses
All statistical analyses were run using JMP software, version 4.0 (SAS Institute, Inc., Cary,
NC). A significance level of 0.05 was used for all analyses except for selection of covariates
(see below for details).
Statistical analyses used lesion volumes from the MRI closest to the time of the nutrition
assessment. For most subjects the MRI and nutrition assessments were separated by less than
one year. In order to minimize the time interval, either assessment could precede the other.
Self-report of hypertension, diabetes, and heart disease was obtained from the closest annual
DDES instrument. Analyses first assessed the potential for responder bias. Bivariate
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comparisons were made between individuals with acceptable FFQs (“responders”) and those
who either did not return a questionnaire or who returned an unacceptable one (together
categorized as “nonresponders”). Variables examined included age, sex, race, lesion volume,
hypertension, diabetes, heart disease, and group (depression or comparison). Bivariate
comparisons between responder category (responder/nonresponder) and covariates were
conducted using (a) Chi-squared test if the covariates were categorical (sex, race, hypertension,
diabetes, heart disease, and group), and (b) t-test if the variables were continuous (age and
lesion volume).
Simple regression analyses [39] were performed to examine the relationships between lesion
volume and each of the two nutrients of interest, total vitamin D and total calcium, which were
calculated by combining food and dietary supplement estimates for each nutrient.
To examine the diet and lesion relationships while controlling for potential confounders, two
separate multivariable regression models [39] with lesion volume as the dependent variable
were run, using either total vitamin D or total calcium as the independent variable of interest.
Prior to examining the multivariable associations, covariates were selected for inclusion by
backwards stepwise regression. A cutoff of p>0.2 was used for exclusion of covariates.
Covariates examined in this way included age, sex, race (white/nonwhite), hypertension (yes/
no), diabetes (yes/no), heart disease (yes/no), BMI (kg/m2), total energy (kcals), group
(depression/comparison), lesion load (high/low), and group*lesion load (interaction term).
Once covariates were selected and either vitamin D or calcium was added as an independent
variable, interaction terms were examined and included in final model if p<0.05. Interaction
terms of interest were vitamin D or calcium and group (depression/comparison), and vitamin
D or calcium and lesion load (high/low). Lastly, a multivariable regression model was run
which included both vitamin D and calcium.
3. Results
3.1. Description of sample
A total of 287 subjects were determined to be eligible to receive an FFQ questionnaire, of
whom 232 (81%) successfully completed it. The earliest FFQ assessment was used for all
except three subjects (1%). For those three subjects who had returned an unacceptable initial
questionnaire, the earliest acceptable subsequent FFQ was used. Nonrespondents (those who
did not return an FFQ or returned an unacceptable one) did not differ from respondents in terms
of age, sex, race, lesion volume, hypertension, diabetes, or heart disease, but were more likely
to have been in the depression group. All subjects had complete data except for six subjects
who had missing BMI and eleven subjects who did not respond to the question on vitamin use.
3.2. Group differences
Sample characteristics (n=232) are shown in Table 1. The study group is presented as a whole
and also divided into four groups based upon group (depression/comparison) and lesion load
(high/low). Nutrient intake estimates for calcium and vitamin D are presented as totals, and as
amounts from foods and dietary supplements. Groups exhibited significant differences in age,
hypertension, BMI, calcium intake, and lesion volume. Mean lesion volume (±standard
deviation) was 6.1 mL (±8.0), with a range of 0.7 to 61.8. A Shapiro-Wilks test for normality
was performed for total lesion volume. It indicated that lesion volume was not normally
distributed (W = 0.55, p < 0.001). A new variable for the logarithmic transformation (natural
log) of lesion volume (logLESION) was created, which visually had an improved distribution
although was also not normal (W = 0.94, p < 0.001). Geometric mean for lesion volume was
included in Table 1 as a measure of central tendency that is less prone to distortion from outliers.
In addition, geometric means may be easier to interpret than logarithmic values given that they
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have the same units as the original variable (lesion volume). Bivariate analyses between
logLESION and both vitamin D and calcium were performed. Both vitamin D (β = 0.0008, SE
= 0.0002, t = 3.7, p < 0.001) and calcium (β = 0.0002, SE = 0.00008, t = 2.1, p = 0.04) were
significantly positively associated with logLESION.
3.3. Multivariable regression models
Backwards stepwise regression for selection of covariates led to elimination (at p>0.2) of the
following variables: BMI, group*lesion load (interaction term), sex, and race. Covariates
included in the final models were age, hypertension, diabetes, heart disease, total kilocalories,
group (depression/comparison), and lesion load. Calcium by group, calcium by lesion load,
vitamin D by group, and vitamin D by lesion load interaction terms were evaluated and were
found not to be statistically significant, although calcium by lesion load was close to
significance at p=0.055. A multivariable model which examined the association between
logLESION and calcium while controlling for covariates found calcium intake to be positively
associated with lesion volume (β = 0.0001, SE = 0.00006, t = 2.28, p = 0.02). Similarly vitamin
D intake was found to be positively associated with lesion volume (β = 0.0006, SE = 0.0002,
t = 3.56, p < 0.001). Calcium and vitamin D were confirmed to be collinear (p < 0.0001). A
final model was run which included both nutrients: logLESION = β0 + β1 Calcium + β2Vitamin
D + β3Age+ β4Hypertension+ β5Diabetes + β6Heart Disease + β7Kilocalories + β8Group +
β9Lesion Load + ε. Vitamin D retained a positive association with lesion volume (β = 0.0005,
SE = 0.0002, t = 2.74, p = 0.007) while calcium intake was no longer associated with lesion
volume (β = 0.00004, SE = 0.00007, t = 0.5, p = 0.6). Age, diabetes, and lesion load were
positively associated with lesion volume in all three models.
3.4. Summary
Dietary calcium and vitamin D were significantly positively associated with brain lesion
volume is both bivariate and multivariable models.
4. Discussion
The finding of an association between calcium, vitamin D, and brain lesions is consistent with
the hypothesized role of calcium dysregulation in the etiology of brain lesions. Intakes of
calcium and vitamin D were found to be significantly positively associated with brain lesion
volume among elderly individuals. After controlling for potential confounders, calcium and
vitamin D remained significantly associated with lesion volume. These findings raise the
possibility that calcium and vitamin D may have detrimental effects on brain health, and
highlight the need for longitudinal investigations. Potential mechanisms to explain these
relationships include vascular calcification and neurotoxic effects (Fig. 2).
The linkage of calcification and brain lesions has been previously reported. A sub-sample of
the Rotterdam Study of elderly (n=111) showed a positive association between carotid calcium-
containing atherosclerotic plaques and cerebral white matter lesions [14]. A combined analysis
of the Rotterdam and Zoetermeer Studies confirmed the finding of a significant positive
association between carotid atherosclerosis and white matter lesions [40]. The Cardiovascular
Health Study (CHS) found a two-fold increase in the prevalence of brain infarcts in elderly
individuals (n=3,502) with calcified carotid plaques [41]. The CHS found that coronary artery
calcification was also associated with white matter lesions, other brain abnormalities, and
cognitive impairment [13].
Vascular calcification was reported as early as the 19th century when Virchow observed that
calcium deposits within the vasculature comprised bone-like tissue [42]. Multiple mechanisms
have been proposed to explain the etiology of vascular calcification, with bone biology, calcium
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homeostasis, and the inflammatory response having interactive roles [12,43–45]. Specific
mechanisms by which dietary calcium and vitamin D promote vascular calcification are
unclear. Although each of these nutrients has independent roles, high intake of either may result
in increased availability of calcium ions for uptake by vascular tissue, especially among older
adults [46,47]. A high calcium diet has been shown to increase serum calcium concentrations
[46]. Calcium concentrations, in turn, have been positively associated with mineralization of
vascular smooth muscle [48], carotid artery plaque thickness [49], and coronary artery disease
burden [50].
Vitamin D in its hormonal form, calcitriol, functions in the regulation of calcium homeostasis,
partially by modifying intestinal absorption of calcium and partly by actions on osteoblasts
[47]. Calcitriol receptors and activities have been demonstrated in vascular smooth muscle
[51] and may mediate calcification [52,53].
Calcium may also have direct effects on neuronal health (Fig. 2). Calcium dysregulation may
promote neurotoxic mechanisms when membrane permeability to calcium is increased [10].
Indirectly, calcium entry blockers have been shown in rats to ameliorate brain energy
metabolism during reperfusion which may protect the brain from ischemic damage [54]. Data
for humans, however, are not clear.
The finding of a significant relationship between brain lesions and vitamin D, but not calcium
(in the combined model), may indicate that dietary vitamin D has direct or indirect effects on
vascular smooth muscle cells. Demer has speculated that exogenous vitamin D may
preferentially affect the vasculature [55]. However, it is unclear how dietary vitamin D
(cholecalciferol) would affect the vasculature without first being converted to calcitriol (1,25-
dihydroxycholecalciferol), the active hormonal form. Given the relatively high calcium intakes
in the present study, it is likely that this conversion would be down-regulated [47].
The failure to find depression or lesion load to modify the diet and brain lesion relationship
may mean that calcium and vitamin D are associated with brain lesions across a variety of
conditions and severity in the elderly. Alternatively, this failure may indicate an insufficient
sample size to detect such an association. Also of note is that diabetes mellitus was found to
be significantly associated with lesion volumes in the multivariable models. We speculate that
the diabetes and lesion association is related to sub-optimal renal function, as the damaged
kidneys may be responsible for excessive calcium retention. However, laboratory measures of
renal function were not available so this hypothesis could not be tested.
This study has several limitations including the modest sample size. The cross-sectional design
precludes confirmation of an etiological effect of diet on brain lesions, but it does permit
hypothesis generation. The length of time likely required for development of brain lesions
combined with a lack of historical dietary data make interpretation of any association even
more difficult. An epidemiological rather than a biochemical approach was employed for this
study so readers should be cautioned that discussion of physiological mechanisms is purely
speculative. This project did not incorporate any measurements of calcium metabolism, vitamin
D status, vascular calcification, sun exposure, or renal or hepatic functioning. Because of these
shortcomings, we cannot conclude that dietary factors were related to brain lesions because of
any specific mechanism. The Block FFQ may be insufficient to detect dietary differences
between individuals across the spectrum of brain lesion volumes, due to problems associated
with self-report and the inherently high intra-individual to inter-individual variation of nutrient
intakes, particularly for micronutrients. In addition, the estimate of vitamin D intake from
dietary supplements is not as precise as for calcium supplements, given the lack of specificity
about vitamin D-containing supplements. Use of medications including bisphosphonates,
Payne et al. Page 7













diuretics, and calcium channel blockers were not examined. Finally, generalizability of these
findings to the overall population of elderly individuals is unknown.
This preliminary report indicates the importance of longitudinally evaluating the wide-ranging
effects of dietary calcium and vitamin D, especially in elderly subjects. While it would be
premature to condemn calcium and vitamin D supplementation, it would be equally
irresponsible not to recognize the potentially damaging nervous or vascular effects of high
intakes of these nutrients, particularly at levels currently promoted by health professionals. The
recommended Dietary Reference Intakes (DRIs) for individuals over age 50 are 1200 mg for
calcium and between 400 and 600 IU for vitamin D [56], and vitamin D recommendations are
currently being increased [28]. Mean intakes among our study population were approximately
equal to the DRI for calcium (mean = 1280 mg) and were lower than current recommendations
for vitamin D (mean = 341 IU). Use of dietary supplements accounted for over one-third of
calcium and one-half of vitamin D intakes in this study sample.
In conclusion, evidence of a positive association between brain lesion volume and intakes of
both calcium and vitamin D was found among elderly individuals with and without depression
in this preliminary study. These results are consistent with an association between calcium
dysregulation and brain lesions. These findings need to be confirmed in a larger sample,
particularly one which includes a wide range of conditions and lesion severities. In addition,
future studies should incorporate biochemical measures. Evaluation of the wide-ranging effects
on health of high calcium and vitamin D intakes are particularly critical at a time when both
nutrients are being promoted for their potential protective effects for osteoporosis and other
conditions. Randomized clinical trials are needed in order to confirm etiological relations
between these micronutrients and brain lesions, and to determine whether vascular calcification
or other mechanism explains such a relationship.
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Figure 1. Brain lesions seen on magnetic resonance imaging (MRI)1
1Lesions, believed to be of ischemic origin, occur with aging but particularly with late-life
depression. These lesions may damage mood regulation pathways (leading to depression) or
cause cognitive impairment. Lesions are shown here on a proton density image (left), fluid-
attenuated inversion recovery (FLAIR) image (center), and tissue classification image (right).
Lesions are red on tissue classification image. Images are courtesy of the Neuropsychiatric
Imaging Research Laboratory at Duke University.
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Figure 2. Proposed mechanism for the relationship between calcium and brain lesions1
1Dietary calcium and vitamin D may promote brain lesions via vascular calcification. High
intakes may lead to calcium retention, particularly in the presence of renal disease. Calcium
retention combined with atherosclerotic and inflammatory processes may promote vascular
calcification which, in turn, may lead to ischemia, neuronal death, and brain lesions. Calcium
may also have direct neurotoxic effects which lead to brain lesions.
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